2C-G

2C-G
Clinical data
Other names	2C-G-0; 2,5-Dimethoxy-3,4-dimethylphenethylamine; 3,4-Dimethyl-2,5-dimethoxyphenethylamine; 3-Methyl-2C-D
Routes of; administration	Oral
Drug class	Serotonergic psychedelic; Hallucinogen
ATC code	None;
Legal status
Legal status	In general Unscheduled;
Pharmacokinetic data
Duration of action	18–30 hours
Identifiers
	IUPAC name 2-(2,5-dimethoxy-3,4-dimethylphenyl)ethan-1-amine;
CAS Number	207740-18-9 ;
PubChem CID	22238091;
ChemSpider	21106224 ;
UNII	DTG7FMO01J;
ChEMBL	ChEMBL127202 ;
CompTox Dashboard (EPA)	DTXSID70174848 ;
Chemical and physical data
Formula	C12H19NO2
Molar mass	209.289 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COc1c(C)c(C)c(cc1CCN)OC;
	InChI InChI=1S/C12H19NO2/c1-8-9(2)12(15-4)10(5-6-13)7-11(8)14-3/h7H,5-6,13H2,1-4H3 ; Key:NFOHGLKGLZIHJQ-UHFFFAOYSA-N ;
	(what is this?) (verify)

2C-G, or 2C-G-0, also known as 3,4-dimethyl-2,5-dimethoxyphenethylamine or as 3-methyl-2C-D, is a psychedelic phenethylamine of the 2C family. First synthesized by Alexander Shulgin, it has structural and pharmacodynamic properties similar to 2C-D and Ganesha (G). The drug has a number of known homologues, which are known as the 2C-G series of compounds.